Literature DB >> 2325476

[Hepatitis B and hepatitis delta in young inmates].

J M Bayas1, M Bruguera, V Martín, A Mayor, M L de la Fuente, A Laliga, L Salleras.   

Abstract

The prevalence of infection by hepatitis B (HBV) and delta (HDV) viruses and presumably related variables were evaluated in a prison for young male convicts, aged 16-21 years (n = 686), 55.1% of convicts were positive for one or more VHB markers, and 7.1% were positive for HBsAg; 89.7% of these were negative for IgM anti-HBc (chronic carriers), while 36.6% were positive for HBeAg. Anti-delta antibodies were detected in 37.5% of chronic carriers. The seropositivity of HVB markers was much higher in parenteral drug abusers (PDA) as compared with non PDA (76.3% vs 26.7%, p less than 0.0000001, OR = 8.82). Among PDA, it was higher in regular users than in occasional ones (83.3% vs 62.9%, p = 0.0001, OR = 2.95) and in those who had acquired the habit at an early age (p = 0.035). The stratified analysis also showed an association of VHB infection with other variables, basically ethical and prison-related. The possibility to develop active immunization programs is evaluated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2325476

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  3 in total

1.  Prevalence of hepatitis B infection in long-stay mentally handicapped adults.

Authors:  F Asensio; J M Bayas; M J Bertran; M A Asenjo
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Prisons: an important link in the elimination of Hepatitis B.

Authors:  A Barreira-Díaz; M Buti
Journal:  Rev Esp Sanid Penit       Date:  2021 Sep-Dec

Review 3.  Diagnosis and treatment of hepatitis B. What contributions can prisons make?

Authors:  M Vergara
Journal:  Rev Esp Sanid Penit       Date:  2021 Sep-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.